🎉 M&A multiples are live!
Check it out!

Bristol-Myers Squibb Valuation Multiples

Discover revenue and EBITDA valuation multiples for Bristol-Myers Squibb and similar public comparables like Armata Pharmaceuticals, Vivoryon Therapeutics, and Pharming.

Bristol-Myers Squibb Overview

About Bristol-Myers Squibb

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.


Founded

1933

HQ

United States of America
Employees

34.1K+

Website

bms.com

Financials

LTM Revenue $47.8B

LTM EBITDA $8.7B

EV

$160B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Bristol-Myers Squibb Financials

Bristol-Myers Squibb has a last 12-month revenue of $47.8B and a last 12-month EBITDA of $8.7B.

In the most recent fiscal year, Bristol-Myers Squibb achieved revenue of $48.3B and an EBITDA of $3.2B.

Bristol-Myers Squibb expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Bristol-Myers Squibb valuation multiples based on analyst estimates

Bristol-Myers Squibb P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $45.0B $48.3B XXX XXX XXX
Gross Profit $36.0B $34.3B XXX XXX XXX
Gross Margin 80% 71% XXX XXX XXX
EBITDA $19.4B $3.2B XXX XXX XXX
EBITDA Margin 43% 7% XXX XXX XXX
Net Profit $6.3B $8.0B XXX XXX XXX
Net Margin 14% 17% XXX XXX XXX
Net Debt $30.2B $28.3B XXX XXX XXX

Financial data powered by Morningstar, Inc.

Bristol-Myers Squibb Stock Performance

As of March 14, 2025, Bristol-Myers Squibb's stock price is $59.

Bristol-Myers Squibb has current market cap of $120B, and EV of $160B.

See Bristol-Myers Squibb trading valuation data

Bristol-Myers Squibb Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$160B $120B XXX XXX XXX XXX $2.30

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Bristol-Myers Squibb Valuation Multiples

As of March 14, 2025, Bristol-Myers Squibb has market cap of $120B and EV of $160B.

Bristol-Myers Squibb's trades at 3.4x LTM EV/Revenue multiple, and 18.4x LTM EBITDA.

Analysts estimate Bristol-Myers Squibb's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Bristol-Myers Squibb and 10K+ public comps

Bristol-Myers Squibb Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $160B XXX XXX XXX
EV/Revenue 3.3x XXX XXX XXX
EV/EBITDA 50.5x XXX XXX XXX
P/E -13.4x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF 11.5x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Bristol-Myers Squibb Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Bristol-Myers Squibb Valuation Multiples

Bristol-Myers Squibb's NTM/LTM revenue growth is -6%

Bristol-Myers Squibb's revenue per employee for the last fiscal year averaged $1.4M, while opex per employee averaged $0.8M for the same period.

Over next 12 months, Bristol-Myers Squibb's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Bristol-Myers Squibb's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Bristol-Myers Squibb and other 10K+ public comps

Bristol-Myers Squibb Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 7% XXX XXX XXX XXX
EBITDA Margin 7% XXX XXX XXX XXX
EBITDA Growth -84% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 1% XXX XXX XXX XXX
Revenue per Employee $1.4M XXX XXX XXX XXX
Opex per Employee $0.8M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue 23% XXX XXX XXX XXX
Opex to Revenue 59% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Bristol-Myers Squibb Public Comps

See public comps and valuation multiples for Biopharmaceuticals and Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
Armata Pharmaceuticals XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Bristol-Myers Squibb M&A and Investment Activity

Bristol-Myers Squibb acquired  XXX companies to date.

Last acquisition by Bristol-Myers Squibb was  XXXXXXXX, XXXXX XXXXX XXXXXX . Bristol-Myers Squibb acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Bristol-Myers Squibb

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Bristol-Myers Squibb

When was Bristol-Myers Squibb founded? Bristol-Myers Squibb was founded in 1933.
Where is Bristol-Myers Squibb headquartered? Bristol-Myers Squibb is headquartered in United States of America.
How many employees does Bristol-Myers Squibb have? As of today, Bristol-Myers Squibb has 34.1K+ employees.
Who is the CEO of Bristol-Myers Squibb? Bristol-Myers Squibb's CEO is Dr. Christopher S. Boerner, PhD.
Is Bristol-Myers Squibb publicy listed? Yes, Bristol-Myers Squibb is a public company listed on NYS.
What is the stock symbol of Bristol-Myers Squibb? Bristol-Myers Squibb trades under BMY ticker.
When did Bristol-Myers Squibb go public? Bristol-Myers Squibb went public in 1952.
Who are competitors of Bristol-Myers Squibb? Similar companies to Bristol-Myers Squibb include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics.
What is the current market cap of Bristol-Myers Squibb? Bristol-Myers Squibb's current market cap is $120B
What is the current revenue of Bristol-Myers Squibb? Bristol-Myers Squibb's last 12-month revenue is $47.8B.
What is the current EBITDA of Bristol-Myers Squibb? Bristol-Myers Squibb's last 12-month EBITDA is $8.7B.
What is the current EV/Revenue multiple of Bristol-Myers Squibb? Current revenue multiple of Bristol-Myers Squibb is 3.4x.
What is the current EV/EBITDA multiple of Bristol-Myers Squibb? Current EBITDA multiple of Bristol-Myers Squibb is 18.4x.
What is the current revenue growth of Bristol-Myers Squibb? Bristol-Myers Squibb revenue growth between 2023 and 2024 was 7%.
Is Bristol-Myers Squibb profitable? Yes, Bristol-Myers Squibb is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.